There are currently two approved drugs to treat ALS: riluzole, which can extend lifespan by an average of a few months and has been on the market for 25 年, and the 2017-approved edaravone, which was shown in clinical trials to help patients function for longer into their disease
干细胞疗法
肝脏干细胞疗法
失代偿期肝硬化患者大多不得不选择肝移植, 但捐献器官的供应有限且成本高昂导致等待名单上的死亡率很高 . 自己身体的干细胞有帮助 阅读更多…